Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.
Santoro A, Su WC, Navarro A, Simonelli M, Ch Yang J, Ardizzoni A, Barlesi F, Hyoung Kang J, DiDominick S, Abdelhady A, Chen X, Stammberger U, Felip E.
Santoro A, et al. Among authors: abdelhady a.
Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Lung Cancer. 2022.
PMID: 35298959
Free article.
Clinical Trial.